Rehabilitation Robots Market

Rehabilitation Robots Market Segmentation by Type (Assistive, Therapeutic, Surgical, and Exoskeleton Robot); by Patient Type (Mentally-ill, Disabled, Pediatrics, and Others); and by End-User (Hospital, Orphanage, Nursing Home, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now
Report ID: 4049 | Published On: Feb 02, 2023
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.


In The News

  • March 05, 2021: DIH, a global leader in rehab robotics and virtual reality, has collaborated with Reha Technology agreeing to distribute their robotics products and promote the gait therapy devices in the US and Europe markets.

  • November 12, 2018: Hocoma AG launches a software platform, HocoNet, to connect hospital information systems with Hocoma’s partner devices.


Global Rehabilitation Robots Market Highlights over 2022 - 2031

The global rehabilitation robots market is estimated to garner a robust revenue by growing at a ~26% CAGR over the forecast period, i.e., 2022 – 2031.

The growth of the market can be attributed to the noteworthy increment in the adoption of robots in the healthcare sector worldwide. Factors, such as severe spinal cord injuries, sports injuries, or accidents, cause conditions that require medical treatment, which can last for years. The surge in the prevalence of such medical conditions, which need extended medical rehabilitation, is further estimated to propel market growth. Moreover, the procedure for the treatment of physical and mental disorders is complex, and forthcoming results are always uncertain. Hence, advanced robots are being developed to unravel this problem by facilitating quick recovery for several medical conditions.

Rehabilitation Robots Market Graph

Get more information on this report: Request Sample PDF

The global rehabilitation robots market is also projected to grow on the back of rising spinal cord injury and stroke cases. According to the data provided by World Health Organization, 40 to 80 cases of spinal cord injury are witnessed per million populations globally. Additionally, the increasing utilization of automated machines in the medical field, accompanied by the gradual increment of the geriatric population with crucial disabilities, is also spotted to be another significant growth factor for the market. According to a report published by World Bank, in 2020, 723.184 million people of the global population were aged 65 and over. All these parameters are projected to boost the growth of the global rehabilitation robots market. Moreover, the growing dependency on AI and robots amongst people, backed by the growing digitalization and declining social interaction in society, is further anticipated to fuel the market growth.

The global rehabilitation robots market is segmented by end-user into hospitals, nursing homes, orphanages, and others, out of which, the hospital segment is projected to hold the largest market share over the forecast period, on the back of the availability of 24-hour service for people with all sorts of diseases and disorders, along with the high patient pool in the hospitals. Further, unforeseen changes in people’s lifestyles, such as lack of exercise, poor diet, and others, require proper medical attention, and rehabilitation robots has the requisite potential to treat such patients more effectively. This is expected to boost the adoption of rehabilitation robots in hospitals.  


Major Macro-Economic Indicators Impacting the Market Growth

Global Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Global Rehabilitation Robots Market Regional Synopsis

Regionally, the global rehabilitation robots market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North American region is estimated to witness noteworthy growth over the forecast period, on the back of the remarkable deployment of advanced technology in the region, combined with the growing healthcare sector. The International Federation of Robotics (IFR) release the World Robotics 2020 Industrial Robots report, which showed that 293,200 units of industrial robots were operating in factories of the United States in 2020. Meanwhile, 2.7 million industrial robots were operating in factories and industries around the world.

On the other hand, the market in the Asia Pacific region is anticipated to become the largest market over the forecast period owing to the noteworthy increment in adoption of robots in each sector, and growing awareness about mental disorders.

Rehabilitation Robots Market Share Graph

Get more information on this report: Request Sample PDF

The global rehabilitation robots market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook


Rehabilitation Robots Market Graph
Get more information on this report: Request Sample PDF

Market Segmentation

Our in-depth analysis of the global rehabilitation robots market includes the following segments:

By Type

  • Assistive Robot
  • Therapeutic Robot
  • Surgical Robot
  • Exoskeleton Robot

By Patient Type

  • Mentally-ill
  • Disabled
  • Pediatrics
  • Others

By End-User

  • Hospital
  • Orphanage
  • Nursing Home
  • Others

Growth Drivers

  • High Share of Aging Population with Physical and Mental Disorders
  • Evolution of Digitalization and Adoption of Robots
  • Frequent Occurrence of Strokes and Spinal Cord Injuries

Challenges

  • High-Priced Manufacturing and Development of Required Contemporary A.I.
  • Scarcity of Distribution Channels for Rehabilitation Robots


Global Healthcare Expenditure per Capita Graph
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Hocoma AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • MAN&TEL Co., Ltd.
    • CYBERDYNE Inc.
    • Myomo Inc.
    • ReWalk Robotics Ltd.
    • Reha Technology AG
    • Motek Medical B.V.
    • Ekso Bionics Holdings, Inc.
    • BIONIK Laboratory Corp.
    • ABILITY Network Inc.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the rehabilitation robots market?

Ans: The increasing number of senior citizens with physical disorders is driving the growth of the market.

2) What would be the CAGR of rehabilitation robots market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~26% over the forecast period, i.e., 2022-2031.

3) What are the challenges affecting the rehabilitation robots market growth?

Ans: The expensive manufacturing and development of required technology and the lack of affordability for the people are estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of rehabilitation robots market in future?

Ans: The Asia Pacific region is anticipated to provide more business opportunities for the growth of the market over the forecast period on the back of increased production of robots in the region.

5) Who are the major players dominating the rehabilitation robots market?

Ans: The major players in the market are Hocoma AG, MAN&TEL Co., Ltd., CYBERDYNE Inc., Myomo Inc., ReWalk Robotics Ltd., Reha Technology AG, Motek Medical B.V., Ekso Bionics Holdings, Inc., BIONIK Laboratory Corp., and ABILITY Network Inc.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the rehabilitation robots market?

Ans: The market is segmented by type, patient type, end-user, and by region.

8) Which sub-segment captures the largest market size in the end-user segment in the rehabilitation robots market?

Ans: The hospital segment is anticipated to hold the largest market size over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample